Literature DB >> 31215805

Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease.

Nimrit Goraya1,2, Jan Simoni3, Lauren N Sager4, Abdullah Mamun5, Nicolaos E Madias6, Donald E Wesson7,8.   

Abstract

Previous studies have shown that acid (H+) retention in patients with chronic kidney disease (CKD) but without metabolic acidosis increases as the estimated glomerular filtration rate (eGFR) decreases over time. The present study examined whether changes in urine excretion of the pH-sensitive metabolite citrate predicted changes in H+ retention over time in similar patients with CKD that were followed for 10 yr. We randomized 120 CKD2 nondiabetic, hypertension-associated nephropathy patients with plasma total CO2 of >24 mM to receive 0.5 meq·kg body wt-1·day-1 NaHCO3 ([Formula: see text]; n = 40), 0.5 meq·kg body wt-1·day-1 NaCl (NaCl; n = 40), or usual care (UC; n = 40). We assessed eGFR (CKD-EPI) and H+ retention by comparing the observed with expected plasma total CO2 increase 2 h after an oral NaHCO3 bolus (0.5 meq/kg body wt). Although 10 yr versus baseline eGFR was lower for each group, 10-yr eGFR was higher (P < 0.01) in [Formula: see text] (59.6 ± 4.8 ml·min-1·1.73 m-2) than NaCl and UC (52.1 ± 5.9 and 52.3 ± 4.1 ml·min-1·1.73 m-2, respectively) groups. Less eGFR preservation was associated with higher 10-yr versus baseline H+ retention in the NaCl group (26.5 ± 13.1 vs. 18.2 ± 15.3 mmol, P < 0.01) and UC group (24.8 ± 11.3 vs. 17.7 ± 10.9 mmol, P < 0.01) and with lower 10-yr versus baseline 8-h urine citrate excretion (UcitrateV) for the NaCl group (162 ± 47 vs. 196 ± 52 mg, respectively, P < 0.01) and UC group (153 ± 41 vs. 186 ± 42 mg, respectively, P < 0.01). Conversely, better eGFR preservation in the [Formula: see text] group was associated with no differences in 10-yr versus baseline H+ retention (14.2 ±13.5 vs. 16.1 ± 15.1 mmol, P = 1.00) or UcitrateV (212 ± 45 vs. 203 ± 49 mg, respectively, P = 0.74). An overall generalized linear model for repeated measures showed that UcitrateV predicted H+ retention (P < 0.01). Less eGFR preservation in patients with CKD2 without metabolic acidosis was associated with increased H+ retention that was predicted by decreased UcitrateV.

Entities:  

Keywords:  acid retention; acidosis; bicarbonate; chronic kidney disease; glomerular filtration rate

Year:  2019        PMID: 31215805     DOI: 10.1152/ajprenal.00044.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  9 in total

1.  Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.

Authors:  Donald E Wesson; Jerry M Buysse; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

Review 2.  Functional Reserve of the Kidney.

Authors:  Armando Armenta; Magdalena Madero; Bernardo Rodriguez-Iturbe
Journal:  Clin J Am Soc Nephrol       Date:  2021-11-10       Impact factor: 8.237

Review 3.  Effects of acid on bone.

Authors:  David A Bushinsky; Nancy S Krieger
Journal:  Kidney Int       Date:  2022-03-26       Impact factor: 18.998

4.  Chronic hepatitis B virus infection increases the risk of upper urinary calculi.

Authors:  Bingbing Hou; Changming Lin; Zongyao Hao
Journal:  BMC Urol       Date:  2022-06-06       Impact factor: 2.090

5.  Metabolic Acidosis and CKD Progression.

Authors:  Nicolaos E Madias
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-07       Impact factor: 8.237

6.  Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.

Authors:  Crystal C Tyson; Alison Luciano; Jennifer L Modliszewski; David L Corcoran; James R Bain; Michael Muehlbauer; Olga Ilkayeva; Shirin Pourafshar; Jenifer Allen; Cassandra Bowman; Joseph Gung; John R Asplin; Jane Pendergast; Laura P Svetkey; Pao-Hwa Lin; Julia J Scialla
Journal:  Am J Kidney Dis       Date:  2021-03-31       Impact factor: 11.072

Review 7.  The Continuum of Acid Stress.

Authors:  Donald E Wesson
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-19       Impact factor: 10.614

8.  Lower bicarbonate level is associated with CKD progression and all-cause mortality: a propensity score matching analysis.

Authors:  Hirotaka Fukasawa; Mai Kaneko; Yuri Uchiyama; Hideo Yasuda; Ryuichi Furuya
Journal:  BMC Nephrol       Date:  2022-03-04       Impact factor: 2.388

9.  Urine oxalate and citrate excretion in patients with kidney stone disease: An ab initio clinical prediction.

Authors:  Calyani Ganesan; Alan C Pao
Journal:  Physiol Rep       Date:  2021-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.